Seminars in Oncology
Volume 33, Issue 5 , Pages 527-533 , October 2006

Epidemiologic Aspects of Renal Cell Carcinoma

  • Joseph K. McLaughlin

      Affiliations

    • International Epidemiology Institute, Rockville, MD.
    • Department of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN.
    • Corresponding Author InformationAddress correspondence to Joseph K. McLaughlin, PhD, International Epidemiology Institute, 1455 Research Blvd, Suite 550, Rockville, MD 20850, USA.
    • ,
  • Loren Lipworth

      Affiliations

    • International Epidemiology Institute, Rockville, MD.
    • Department of Preventive Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN.
    • ,
  • Robert E. Tarone

      Affiliations

    • International Epidemiology Institute, Rockville, MD.
    • Department of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN.

References 

  1. Mathew A, Devesa SS, Fraumeni JF, et al. Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev. 2002;11:171–178
  2. Parkin CM, Whelan SL, Ferlay J, et al. Cancer Incidence in Five Continents, Volume VIII. Lyon, France: International Agency for Research on Cancer; 2002;IARC Scientific Publications No. 155
  3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130
  4. National Cancer Institute. DCCPS, Surveillance Research Program, Cancer Statistics Branch (SEER Program Public Use Data Tapes 1973-2002). 2005;April
  5. Kosary CL, McLaughlin JK. Kidney and renal pelvis. In:  Miller BA,  Ries LAG,  Hankey BE editor. Cancer Statistics Review: 1973-1990. Bethesda, MD: National Cancer Institute; 1993;p. Xl–X22NIH Pub. No. 93-2789.
  6. Mindrup SR, Pierre JS, Dahmoush L, et al. The prevalence of renal cell carcinoma diagnosed at autopsy. Br J Urol. 2005;95:31–33
  7. Chow WH, Devesa SS, Warren JL, et al. The rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628–1631
  8. Noordzij MA, Mickisch GH. The genetic make-up of renal cell tumors. Urol Res. 2004;32:251–254
  9. Knudson AG. Preface. Curr Mol Med. 2004;4:i–ii
  10. Cohen HT, McGovern FJ. Renal cell carcinoma. N Engl J Med. 2005;353:2477–2490
  11. McLaughlin JK, Lipworth L. Epidemiologic aspects of renal cell cancer. Semin Oncol. 2000;27:1–10
  12. Bennington JL, Laubscher FA. Epidemiologic studies of carcinoma of the kidney (I. Association of renal adenocarcinoma with smoking). Cancer. 1968;21:1069–1071
  13. Wynder EL, Mabuchi K, Whitemore WF. Epidemiology of adenocarcinoma of the kidney. J Natl Cancer Inst. 1974;53:1619–1634
  14. Armstrong B, Garrod A, Doll R. A retrospective study of renal cancer with special reference to coffee and animal protein consumption. Br J Cancer. 1976;33:127–136
  15. Kolonel LN. Association of cadmium with renal cancer. Cancer. 1976;37:1782–1787
  16. McLaughlin JK, Mandel JS, Blot WJ, et al. Population-based case-control study of renal cell carcinoma. J Natl Cancer Inst. 1984;72:275–284
  17. Yu MC, Mack TM, Hanesch R, et al. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst. 1986;77:351–356
  18. Goodman MT, Morgenstern H, Wynder EL. A case-control study of factors affecting the development of renal cell cancer. Am J Epidemiol. 1986;124:926–941
  19. Brownson RC. A case-control study of renal cell carcinoma in relation to occupation, smoking, and alcohol consumption. Arch Environ Health. 1988;43:238–241
  20. Asal NR, Risser DR, Kadamani S, et al. Risk factors in renal cell carcinoma (I. Methodology, demographics, tobacco, beverage use, and obesity). Cancer Detect Prev. 1988;11:359–377
  21. McCredie M, Ford JM, Stewart JH. Risk factors for cancer of the renal parenchyma. Int J Cancer. 1988;42:13–16
  22. Sharpe CR, Rochon JE, Adam JM, et al. Case-control study of hydrocarbon exposures in patients with renal cell carcinoma. Can Med Assoc J. 1989;140:1309–1318
  23. La Vecchia C, Negri E, D’Avanzo B, et al. Smoking and renal cell carcinoma. Cancer Res. 1990;50:5231–5233
  24. Maclure M, Willett W. A case-control study of diet and risk of renal adenocarcinoma. Epidemiology. 1990;1:430–440
  25. Talamini R, Baron AE, Barra S, et al. A case-control study of risk factors for renal cell cancer in northern Italy. Cancer Causes Control. 1990;1:125–131
  26. Partanen T, Heikkila P, Hernberg S, et al. Renal cell cancer and occupational exposure to chemical agents. Scand J Work Environ Health. 1991;17:231–239
  27. McLaughlin JK, Gao YT, Gao RN, et al. Risk factors for renal cell cancer in Shanghai, China. Int J Cancer. 1992;52:562–565
  28. Kreiger N, Marrett LD, Dodds L, et al. Risk factors for renal cell carcinoma: Results of a population-based case-control study. Cancer Causes Control. 1993;4:101–110
  29. Finkle WD, McLaughlin JK, Rasgon SA, et al. Increased risk of renal cell cancer among women using diuretics in the United States. Cancer Causes Control. 1993;4:555–558
  30. Benhamou S, Lenfant M-H, Ory-Paoletti C, et al. Risk factors for renal cell carcinoma in a French case-control study. Int J Cancer. 1993;55:32–36
  31. Hiatt RA, Tolan K, Quesenberg CP. Renal cell carcinoma and thiazide use: A historical case-control study. Cancer Causes Control. 1994;5:319–325
  32. Weinmann S, Glass AG, Weiss NS, et al. Use of diuretics and other antihypertensive medications in relation to the risk of renal cell cancer. Am J Epidemiol. 1994;140:792–804
  33. Muscat JE, Hoffmnn D, Wynder EL. The epidemiology of renal cell carcinoma: A second look. Cancer. 1995;75:2552–2557
  34. McLaughlin JK, Lindblad P, Mellemgaard A, et al. International renal-cell cancer study (I. Tobacco use). Int J Cancer. 1995;60:194–198
  35. McCredie M, Stewart JH. Risk factors for kidney cancer in New South Wales: I. Cigarette smoking. Eur J Cancer. 1992;28A:2050–2054
  36. McCredie M, Stewart JH. Risk factors for kidney cancer in New South Wales (II. Urological disease, hypertension, obesity and hormonal factors). Cancer Causes Control. 1992;3:323–331
  37. Mellemgaard A, Engholm G, McLaughlin JK, et al. Risk of renal cell carcinoma in Denmark (I. Role of socioeconomic status, tobacco use, beverages, and family history). Cancer Causes Control. 1994;5:105–113
  38. Mellemgaard A, Niwa S, Mehl ES, et al. Risk factors for renal cell carcinoma in Denmark (II. Role of medication and medical history). Int J Epidemiol. 1994;23:923–930
  39. Mellemgaard A, Engholm G, McLaughlin JK, et al. Risk of renal cell carcinoma in Denmark (III. Role of weight, physical activity, and reproductive factors). Int J Cancer. 1994;56:66–71
  40. Mellemgaard A, Engholm G, McLaughlin JK, et al. Occupational risk factors for renal cell carcinoma in Denmark. Scand J Work Environ Health. 1994;20:160–165
  41. Chow W-H, McLaughlin JK, Linet MS, et al. Use of analgesics and risk of renal cell cancer. Int J Cancer. 1994;59:467–470
  42. Chow W-H, Gridley G, McLaughlin JK, et al. Protein intake and risk of renal cell cancer. J Natl Cancer Inst. 1994;86:1131–1139
  43. Chow WH, McLaughlin JK, Mandel JS, et al. Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev. 1996;5:17–21
  44. Schlehofer B, Heuer C, Blettner M, et al. Occupation, smoking and demographic factors, and renal cell carcinoma in Germany. Int J Epidemiol. 1995;24:51–57
  45. Lindblad P, Wolk A, Bergstrom A, et al. The role of obesity and weight fluctuations in the etiology of renal cell cancer: A population-based case-control study. Cancer Epidemiol Biomarkers Prev. 1994;3:631–639
  46. Lindblad P, Wolk A, Bergstrom R, et al. Diet and risk of renal cell cancer: A population-based case-control study. Cancer Epidemiol Biomarkers Prev. 1997;6:215–223
  47. Boeing H, Schlehofer B, Wahrendorf J. Diet, obesity and risk for renal cell carcinoma: Results from a case-control study in Germany. Z Ernahrungswiss. 1997;36:3–11
  48. Yuan JM, Castelao JE, Gago-Dominguez M, et al. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer. 1998;77:1508–1513
  49. Bianchi GD, Cerhan JR, Parker AS, et al. Tea consumption and risk of bladder and kidney cancers in a population-based case-control study. Am J Epidemiol. 2000;151:377–383
  50. Pesch B, Haerting J, Ranft U, et al. MURC Study Group Occupational risk factors for renal cell carcinoma: Agent-specific results from a case-control study in Germany (Multicenter urothelial and renal cancer study). Int J Epidemiol. 2000;29:1014–1024
  51. Semenza JC, Ziogas A, Largent J, et al. Gene-environment interactions in renal cell carcinoma. Am J Epidemiol. 2001;153:851–859
  52. Hu J, Mao Y, White K, et al. Overweight and obesity in adults and risk of renal cell carcinoma in Canada. Soz Praventivmed. 2003;48:178–185
  53. McLaughlin JK, Hrubec Z, Heineman EF, et al. Renal cancer and cigarette smoking in a 26-year followup of U.S. veterans. Public Health Rep. 1990;105:535–537
  54. Coughlin SS, Neaton JD, Randall B, et al. Predictors of mortality from kidney cancer in 332,547 men screened for the Multiple Risk Factor Intervention Trial. Cancer. 1997;79:2171–2177
  55. Heath CW, Lally CA, Calle EE, et al. Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer. Am J Epidemiol. 1997;145:607–613
  56. Chow WH, Gridley G, Fraumeni JR, et al. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000;343:1305–1311
  57. Mahabir S, Leitzmann MK, Pietinen P, et al. Physical activity and renal cell cancer risk in a cohort of male smokers. Int J Cancer. 2004;108:600–605
  58. Nicodemus KK, Sweeney C, Folsom AR. Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer. 2004;108:115–121
  59. Van Dijk BAC, Schouten Lj, Kiemeney LALM, et al. Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: Results from the Netherlands Cohort Study. Am J Epidemiol. 2004;160:1159–1167
  60. Bjorge T, Tretli S, Engelend A. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol. 2004;160:1168–1176
  61. Rashidkhani B, Lindblad P, Wolk A. Fruits, vegetables and risk of renal cell carcinoma: A prospective study of Swedish women. Int J Cancer. 2005;113:451–455
  62. Flaherty KT, Fuchs CS, Colditz GA, et al. A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control. 2005;16:1099–1106
  63. Choi MY, Jee SH, Sull JW, et al. The effect of hypertension on the risk for kidney cancer in Korean men. Kidney Int. 2005;67:647–652
  64. Lindgren AM, Nissinen AM, Tuomilehto JO, et al. Cancer pattern among hypertensive patients in North Karelia, Finland. J Hum Hypertens. 2005;19:373–379
  65. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of renal cell carcinoma in the European Prospective Investication into Cancer and Nutrition. Int J Cancer. 2006;118:728–738
  66. McLaughlin JK, Chow WH, Mandel JS, et al. International renal-cell cancer study (VIII. Role of diuretics, other anti-hypertensive medications and hypertension). Int J Cancer. 1995;63:216–221
  67. McCredie M, Pommer W, McLaughlin JK, et al. International renal cell cancer study (II. Analgesics). Int J Cancer. 1995;60:345–349
  68. Mellemgaard A, Odaka N, Lindblad P, et al. International renal-cell cancer study (III. Role of weight, height, physical activity and use of amphetamines). Int J Cancer. 1995;60:350–354
  69. Mandel JS, McLaughlin JK, Schlehofer B, et al. International renal-cell cancer study (IV. Occupation). Int J Cancer. 1995;61:601–605
  70. Lindblad P, Chow WH, Chan J, et al. International renal-cell cancer study (V. Reproductive factors, gynecologic operations and exogenous hormones). Int J Cancer. 1995;61:192–198
  71. Schlehofer B, Pommer W, Mellemgaard A, et al. International renal-cell cancer study (VI. The role of medical and family history). Int J Cancer. 1996;66:723–726
  72. Wolk A, Gridley G, Niwa S, et al. International renal-cell cancer study (VII. Role of diet). Int J Cancer. 1996;65:67–73
  73. Vineis P, Alavanja M, Buffler P, et al. Tobacco and cancer: Recent epidemiological evidence. J Natl Cancer Inst. 2004;96:99–106
  74. Yuan JM, Castelao JE, Gago-Dominguez M, et al. Tobacco use in relation to renal cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1998;5:429–433
  75. Benichou J, Chow WH, McLaughlin JK, et al. Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol. 1998;148:424–430
  76. Hunt JD, van der Hel OL, McMillan GP, et al. Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies. Int J Cancer. 2005;114:101–108
  77. Bergstrom A, Hsieh CC, Lindblad P, et al. Obesity and renal cell cancer—A quantitative review. Br J Cancer. 2001;85:984–990
  78. Pan SY, Johnson KC, Ugnat A-M, et al. Association of obesty and cancer risk in Canada. Am J Epidemiol. 2004;159:259–268
  79. Samanic C, Gridley G, Chow W-H, et al. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control. 2003;15:35–43
  80. Bergstrom A, Pisani P, Tenet V, et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001;91:421–430
  81. Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–591
  82. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000;92:1472–1489
  83. Gago-Dominguez M, Castelao JE, Yuan JM, et al. Lipid peroxidation: A novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control. 2002;13:287–293
  84. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199–206
  85. Shapiro JA, Williams MA, Weiss NS, et al. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol. 1999;149:521–530
  86. Batty GD, Shipley MJ, Marmot MG, et al. Blood pressure and site-specific cancer mortality: Evidence from the original Whitehall study. Br J Cancer. 2003;89:1243–1247
  87. Rosenberg L, Stephenson WP, Rao RS, et al. The diagnosis of renal cell cancer in relation to hypertension (United States). Cancer Causes Control. 1998;9:611–614
  88. National Toxicology Program: Toxicology and carcinogenesis studies of furosemide in F344/N rats and B6C3F mice. Research Triangle Park, NC: National Toxicology Program; 1989;NTP Technical Report No. 356
  89. National Toxicology Program: Toxicology and carcinogenesis studies of hydrochlorothiazide in F344/N rats and B6C3F mice. Research Triangle Park, NC: National Toxicology Program; 1989;NTP Technical Report No. 357
  90. Fryzek JP, Poulson AH, Johnsen SP, et al. A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer. 2005;92:1302–1306
  91. McLaughlin JK, Blot WJ, Mehl ES, et al. Relation of analgesic use to renal cancer: Population-based findings. NCI Monogr. 1985;69:213–215
  92. Derby LE, Jick H. Acetaminophen and renal and bladder cancer. Epidemiol. 1996;7:358–362
  93. Rosenberg L, Rao RS, Palmer JR, et al. Transitional cell cancer of the urinary tract and renal cell cancer in relation to acetaminophen use (United States). Cancer Causes Control. 1998;9:83–88
  94. Gago-Dominguez M, Yuan JM, Castelao JE, et al. Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer. 1999;81:542–548
  95. Kaye JA, Myers MW, Jick H. Acetaminophen and the risk of renal and bladder cancer in the general practice research database. Epidemiol. 2001;12:690–694
  96. Mellemgaard A, Moller H, Jensen OM, et al. Risk of kidney cancer in analgesics users. J Clin Epidemiol. 1992;45:1021–1024
  97. Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 1993;85:307–311
  98. Lindblad P, McLaughlin JK, Mellemgaard A, et al. Risk of kidney cancer among patients using analgesics and diuretics: A population-based cohort study. Int J Cancer. 1993;55:5–9
  99. Wolk A, Lindblad P, Adami HO. Nutrition and renal cell cancer. Cancer Causes Control. 1996;7:5–18
  100. Yuan JM, Gago-Dominguez M, Castelao JE, et al. Cruciferous vegetables in relation to renal cell carcinoma. Int J Cancer. 1998;77:211–216
  101. Hu J, Mao Y, White K, et al. Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada. Cancer Causes Control. 2003;14:705–714
  102. Adami HO, McLaughlin JK, Hsing AW, et al. Alcoholism and cancer risk: A population-based study. Cancer Causes Control. 1992;3:419–425
  103. Gago-Dominguez M, Castelao JE, Yuan JM, et al. Increased risk of renal cell carcinoma subsequent to hysterectomy. Cancer Epidemiol Biomarkers Prev. 1999;8:999–1003
  104. Lambe M, Lindblad P, Wuu J, et al. Pregnancy and risk of renal cell cancer: A population-based study in Sweden. Br J Cancer. 2002;86:1425–1429
  105. Selikoff IJ, Hammond EC, Seidman H. Mortality experience of insulation workers in the United States and Canada, 1943-1976. Ann NY Acad Sci. 1979;330:91–116
  106. Enterline PE, Hartley J, Henderson V. Asbestos and cancer: A cohort followed up to death. Br J Ind Med. 1987;44:396–401
  107. Sali D, Boffetta P. Kidney cancer and occupational exposure to asbestos: A meta-analysis of occupational cohort studies. Cancer Causes Control. 2000;11:37–47
  108. McLaughlin JK. Renal cell cancer and exposure to gasoline: A review. Environ Health Perspect Suppl. 1993;101(suppl 6):111–114
  109. Lynge E, Andersen A, Nilsson R, et al. Risk of cancer and exposure to gasoline vapors. Am J Epidemiol. 1997;145:449–458
  110. International Agency for Research on Cancer. Occupational exposures in petroleum refining; crude oil and major petroleum fuels. IARC Monogr Eval Carcinog Risks Hum. 1989;45:39–117
  111. Wong O, Harris F, Smith TJ. Health effects of gasoline exposure (II. Mortality patterns among petroleum refinery workers). Environ Health Perspect. 1993;101(suppl 6):63–76
  112. Wong O, Trent L, Harris F. Nested case-control study of leukemia, multiple myeloma and kidney cancer in a cohort of petroleum workers exposed to gasoline. Occup Environ Med. 1999;56:217–221
  113. Rushton L. The U.K. oil refinery and distribution centre studies: A 39-year follow-up. Environ Health Perspect. 1993;101(suppl 6):77–84
  114. Schnatter AR, Katz AM, Nicolich MJ, et al. A retrospective mortality study among Canadian petroleum marketing and distribution workers. Environ Health Perspect. 1993;101(suppl 6):85–99
  115. McCredie M, Stewart JH. Risk factors for kidney cancer in New South Wales: IV. Occupation. Br J Ind Med. 1993;50:349–354
  116. Gamble JF, Pearlman ED, Nicolich MJ. A nested case-control study of kidney cancer among refinery/petrochemical workers. Environ Health Perspect. 1996;104:642–650
  117. Lewis RJ, Schnatter AR, Drummond I, et al. Mortality and cancer morbidity in a cohort of Canadian petroleum workers. Occup Environ Med. 2003;60:918–928
  118. Swenberg JA, Lehman-McKeeman LD. α2-Urinary globulin-associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male rats. In:  Capen CC,  Dybing E,  Rice JM editor. Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. Lyon, France: International Agency for Research on Cancer; 1999;p. 95–117IARC Scientific Publication No. 147
  119. Henschler D, Vamvakas S, Lammert M, et al. Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethylene. Arch Toxicol. 1995;69:291–299
  120. Vamvakas S, Bruning T, Thomasson B, et al. Renal cell cancer correlated with occupational exposure to trichloroethene. J Cancer Res Clin Oncol. 1998;124:374–382
  121. Bruning T, Pesch B, Wiesenhutter B, et al. Renal cell cancer risk and occupational exposure to trichloroethylene: Results of a consecutive case-control study in Arnsberg, Germany. Am J Ind Med. 2003;43:274–285
  122. McLaughlin JK, Blot WJ. A critical review of epidemiology studies of trichloroethylene and perchloroethylene and risk of renal cell cancer. Int Arch Occup Environ Health. 1997;70:222–231
  123. Green LC, Lash TL. Re: “Renal cell cancer correlated with occupational exposure to trichloroethylene”. J Cancer Res Clin Oncol. 1999;125:430–432
  124. Cherrie JW, Kromhout H, Semple S. The importance of reliable exposure estimates in deciding whether trichloroethylene can cause kidney cancer. J Cancer Res Clin Oncol. 2001;127:400–404
  125. Blair A, Hartge P, Stewart PA, et al. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: extended follow up. Occup Environ Med. 1998;55:161–171
  126. Boice JD, Marano DE, Fryzek JP, et al. Mortality among aircraft manufacturing workers. Occup Environ Med. 1999;56:581–597
  127. Raaschou-Nielsen O, Hansen J, McLaughlin JK, et al. Cancer risk among workers at Danish companies using Trichloroethylene: A cohort study. Am J Epidemiol. 2003;158:1182–1192
  128. Wong O. Carcinogenicity of trichloroethylene: An epidemiologic assessment. Clin Occup Environ Med. 2004;4:557–589
  129. Stewart JH, Buccianti G, Agodoa L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: Analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol. 2003;14:197–207
  130. Satoh S, Tsuchiya N, Habuchi T, et al. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis. J Urol. 2005;174:1749–1753
  131. Neuzillet Y, Lay F, Luccioni A, et al. De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer. 2005;103:251–257
  132. Land CE. Carcinogenic effects of radiation on the human digestive tract and other organs. In:  Cyston AC,  Albert RE,  Burns FJ, et al. editor. Radiation Carcinogenesis. New York, NY: Elsevier; 1986;p. 347–378
  133. Boice JD, Engholm G, Kleinerman RA, et al. Radiation dose and second-cancer risk in patients treated for cancer of the cervix. Radiat Res. 1988;116:3–55
  134. Spiess H, Mays CW, Chmelvesky B. Radium 224 in humans. In:  Taylor DM,  Mays CW,  Gerber GB, et al. editor. Risks from Radium and Thorotrast. London, UK: British Institute of Radiology; 1989;p. 7–12BIR Report 21

PII: S0093-7754(06)00276-4

doi: 10.1053/j.seminoncol.2006.06.010

Seminars in Oncology
Volume 33, Issue 5 , Pages 527-533 , October 2006

Article Tools